People with Parkinson's disease who have a pacemaker-like device implanted in the brain spend an extra four-plus hours a day free of tremors and involuntary movements than they do on medication, ...

Case marks the beginning of a multi-site pivotal trial to evaluate Abbott’s system for management of treatment-resistant ...

On Feb 24, the FDA approved Medtronic’s BrainSense Adaptive deep brain stimulation, a device that surgeons implant in patients’ chests with electrodes connecting to the brain. The system is ...

New York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS) implantation ...

Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain stimulation. The technique, called “ DeepFocus ,” uses transnasal electrical ...

Side effects of deep brain stimulation in people to treat Parkinson's may include impulsivity and depression. Biomedical ...

Brain scientists have developed DeepFocus, a novel technique to reach the deep brain without invasive surgery to treat mental health disorders.

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

A team of experts from the Icahn School of Medicine at Mount Sinai has become the first in the United States to perform a ...

Deep brain stimulation is most often offered to people with advanced Parkinson's disease who have unstable medication ...